Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
72.27
+0.87 (1.22%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Soleno Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,3141,9381,2281633154
Upgrade
Market Cap Growth
57.88%57.88%7498.61%-50.63%-78.71%17.03%
Upgrade
Enterprise Value
3,0481,6561,176-3598
Upgrade
Last Close Price
72.2744.9540.251.986.1528.95
Upgrade
PB Ratio
13.487.917.791.561.843.37
Upgrade
P/TBV Ratio
13.918.138.25-6.354.96
Upgrade
Debt / Equity Ratio
0.220.220.000.020.030.00
Upgrade
Quick Ratio
15.5515.5514.752.002.665.71
Upgrade
Current Ratio
15.6815.6814.892.142.805.83
Upgrade
Return on Equity (ROE)
-87.35%-87.35%-46.45%-171.05%-97.60%-81.46%
Upgrade
Return on Assets (ROA)
-45.06%-45.06%-23.33%-50.58%-40.11%-38.71%
Upgrade
Return on Capital (ROIC)
-50.57%-50.57%-28.70%-109.16%-63.06%-65.35%
Upgrade
Earnings Yield
-5.31%-9.07%-3.18%-148.97%-94.47%-16.04%
Upgrade
FCF Yield
-2.09%-3.58%-2.03%-128.71%-84.94%-16.42%
Upgrade
Buyback Yield / Dilution
-143.61%-143.61%-96.40%-57.90%-27.39%-83.41%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q